Smith+Nephew plc reports solid financial results for Q4 and full year 2023, showcasing growth in revenue and profit margins. Analyst call scheduled for 27 Feb 2024.
Biktarvy Sales Increased 28% Year-Over-Year to $2.6 billionOncology Sales Increased 71% Year-Over-Year to $527 millionFOSTER CITY, Calif. (BUSINESS WIRE) #Earnings Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter of 2022.“This was a very strong quarter for Gile.
26.11.2021 - (PLX AI) – Novo Nordisk announces impact from Volume Based Procurement for insulin in China.Novo Nordisk expects an estimated negative impact on global sales growth of around 3% in 2022 as a result of reduced prices and reduced volumes of insulin .